AAAAAA
Results:
1-19
|
Results: 19
Authors:
MAINI RN
BREEDVELD FC
KALDEN JR
SMOLEN JS
DAVIS D
MACFARLANE JD
ANTONI C
LEEB B
ELLIOTT MJ
WOODY JN
SCHAIBLE TF
FELDMANN M
Citation: Rn. Maini et al., THERAPEUTIC EFFICACY OF MULTIPLE INTRAVENOUS INFUSIONS OF ANTITUMOR NECROSIS FACTOR-ALPHA MONOCLONAL-ANTIBODY COMBINED WITH LOW-DOSE WEEKLYMETHOTREXATE IN RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 41(9), 1998, pp. 1552-1563
Authors:
ELLIOTT MJ
WOO P
CHARLES P
LONGFOX A
WOODY JN
MAINI RN
Citation: Mj. Elliott et al., SUPPRESSION OF FEVER AND THE ACUTE-PHASE RESPONSE IN A PATIENT WITH JUVENILE CHRONIC ARTHRITIS TREATED WITH MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2), British journal of rheumatology, 36(5), 1997, pp. 589-593
Authors:
MAINI RN
BREEDVELD FC
KALDEN JR
SMOLEN JS
DAVIS D
MACFARLANE JD
ANTONI C
LEEB B
ELLIOTT MJ
WOODY JN
SCHAIBLE TF
FELDMANN M
Citation: Rn. Maini et al., LOW-DOSE METHOTREXATE (MTX) SUPPRESSES ANTI-GLOBULIN RESPONSES AND POTENTIATES EFFICACY OF A CHIMERIC MONOCLONAL ANTI-TNF-ALPHA ANTIBODY (CA2) GIVEN REPEATEDLY IN RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 40(9), 1997, pp. 571-571
Authors:
VANOOSTEN BW
BARKHOF F
TRUYEN L
BORINGA JB
BERTELSMANN FW
VONBLOMBERG BME
WOODY JN
HARTUNG HP
POLMAN CH
Citation: Bw. Vanoosten et al., INCREASED MRI ACTIVITY AND IMMUNE ACTIVATION IN 2 MULTIPLE-SCLEROSIS PATIENTS TREATED WITH THE MONOCLONAL ANTITUMOR NECROSIS FACTOR ANTIBODY CA2, Neurology, 47(6), 1996, pp. 1531-1534
Authors:
WALKER RE
SPOONER KM
KELLY G
MCCLOSKEY V
WOODY JN
FALLOON J
BASELER M
PISCITELLI SC
DAVEY RT
POLIS MA
KOVACS JA
MASUR H
LANE HC
Citation: Re. Walker et al., INHIBITION OF IMMUNOREACTIVE TUMOR-NECROSIS-FACTOR-ALPHA BY A CHIMERIC ANTIBODY IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, The Journal of infectious diseases, 174(1), 1996, pp. 63-68
Authors:
PLEVY SE
CARRAMANZANA NM
DEEM RL
WOODY JN
TARGAN SR
Citation: Se. Plevy et al., CLINICAL IMPROVEMENT IN CROHNS-DISEASE (CD) PATIENTS TREATED WITH ANTI-TNF-ALPHA CORRELATES WITH DOWN-REGULATED MUCOSAL T-HELPER-1 RESPONSES, Gastroenterology, 110(4), 1996, pp. 993-993
Authors:
SANDS BE
PODOLSKY DK
TREMAINE WJ
SANDBORN WJ
RUTGEERTS PJ
HANAUER SB
MAYER L
TARGAN SR
DEWOODY KL
BRAAKMAN TAJ
WOODY JN
Citation: Be. Sands et al., CHIMERIC MONOCLONAL ANTITUMOR NECROSIS FACTOR ANTIBODY (CA2) IN THE TREATMENT OF SEVERE, STEROID-REFRACTORY ULCERATIVE-COLITIS (UC), Gastroenterology, 110(4), 1996, pp. 1008-1008
Authors:
TARGAN SR
RUTGEERTS P
HANAUER SB
VANDEVENTER SJH
MAYER L
PRESENT DH
BRAAKMAN TAJ
WOODY JN
Citation: Sr. Targan et al., A MULTICENTER TRIAL OF ANTITUMOR NECROSIS FACTOR (TNF) ANTIBODY (CA2)FOR TREATMENT OF PATIENTS WITH ACTIVE CROHNS-DISEASE, Gastroenterology, 110(4), 1996, pp. 1026-1026
Authors:
PALEOLOG EM
HUNT M
ELLIOTT MJ
FELDMANN M
MAINI RN
WOODY JN
Citation: Em. Paleolog et al., DEACTIVATION OF VASCULAR ENDOTHELIUM BY MONOCLONAL ANTITUMOR NECROSISFACTOR-ALPHA ANTIBODY IN RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 39(7), 1996, pp. 1082-1091
Authors:
MAINI RN
ELLIOT MJ
LONGFOX A
FELDMANN M
KALDEN JR
ANTONIO C
SMOLEN JS
LEEB B
BREEDVELD FC
MACFARLANE JD
BIJL H
WOODY JN
Citation: Rn. Maini et al., CLINICAL-RESPONSE OF RHEUMATOID-ARTHRITIS (RA) TO ANTI-TNF-ALPHA (CA2) MONOCLONAL-ANTIBODY (MAB) IS RELATED TO ADMINISTERED DOSE AND PERSISTENCE OF CIRCULATING ANTIBODY, Arthritis and rheumatism, 38(9), 1995, pp. 200-200
Authors:
MORELAND LW
PRATT PW
MAYES MD
POSTLETHWAITE A
WEISMAN MH
SCHNITZER T
LIGHTFOOT R
CALABRESE L
ZELINGER DJ
WOODY JN
KOOPMAN WJ
Citation: Lw. Moreland et al., DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER TRIAL USING CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY, CM-T412, IN RHEUMATOID-ARTHRITIS PATIENTS RECEIVING CONCOMITANT METHOTREXATE, Arthritis and rheumatism, 38(11), 1995, pp. 1581-1588
Authors:
ELLIOTT MJ
MAINI RN
FELDMANN M
KALDEN JR
ANTONI C
SMOLEN JS
LEEB B
BREEDVELD FC
MACFARLANE JD
BIJL H
WOODY JN
Citation: Mj. Elliott et al., RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TOTUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS, Lancet, 344(8930), 1994, pp. 1105-1110
Authors:
ELLIOTT MJ
MAINI RN
FELDMANN M
LONGFOX A
CHARLES P
BIJL H
WOODY JN
Citation: Mj. Elliott et al., REPEATED THERAPY WITH MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Lancet, 344(8930), 1994, pp. 1125-1127
Authors:
HABERBERGER RL
LISSNER CR
PODGORE JK
MIKHAIL IA
MANSOUR NS
KEMP L
SPEES D
GLENN JC
HAWN RS
WOODY JN
Citation: Rl. Haberberger et al., ETIOLOGY OF ACUTE DIARRHEA AMONG UNITED-STATES EMBASSY PERSONNEL AND DEPENDENTS IN CAIRO, EGYPT, The American journal of tropical medicine and hygiene, 51(6), 1994, pp. 870-874
Authors:
PALEOLOG EM
KATSIKIS P
HARRIS G
DADDONA P
DALESANDRO MR
KINNEY CS
WOODY JN
FELDMANN M
Citation: Em. Paleolog et al., ANTILIPID-A MONOCLONAL-ANTIBODY HA-1A DECREASES THE CAPACITY OF BACTERIAL LIPOPOLYSACCHARIDE TO ACTIVATE HUMAN VASCULAR ENDOTHELIAL-CELLS BY AN IMMUNE ADHERENCE MECHANISM, Cytokine, 5(6), 1993, pp. 570-577
Authors:
KATSIKIS P
HARRIS G
PAGE T
PALEOLOG E
FELDMAN M
DALESANDRO MR
KINNEY CS
SIEGEL SA
WOODY JN
DADDONA PE
Citation: P. Katsikis et al., ANTILIPID A MONOCLONAL-ANTIBODY HA-1A - IMMUNE-COMPLEX CLEARANCE OF ENDOTOXIN REDUCES TNF-ALPHA, IL-1-BETA AND IL-6 PRODUCTION, Cytokine, 5(4), 1993, pp. 348-353
Authors:
RICHARDS AL
HYAMS KC
WATTS DM
ROZMAJZL PJ
WOODY JN
MERRELL BR
Citation: Al. Richards et al., RESPIRATORY-DISEASE AMONG MILITARY PERSONNEL IN SAUDI-ARABIA DURING OPERATION DESERT SHIELD, American journal of public health, 83(9), 1993, pp. 1326-1329
Authors:
HYAMS KC
BOURGEOIS AL
ESCAMILLA J
BURANS J
WOODY JN
Citation: Kc. Hyams et al., THE NAVY FORWARD LABORATORY DURING OPERATIONS DESERT SHIELD DESERT-STORM, Military medicine, 158(11), 1993, pp. 729-732
Authors:
ELLIOTT MJ
MAINI RN
FELDMANN M
LONGFOX A
CHARLES P
KATSIKIS P
BRENNAN FM
WALKER J
BIJL H
GHRAYEB J
WOODY JN
Citation: Mj. Elliott et al., TREATMENT OF RHEUMATOID-ARTHRITIS WITH CHIMERIC MONOCLONAL-ANTIBODIESTO TUMOR-NECROSIS-FACTOR-ALPHA, Arthritis and rheumatism, 36(12), 1993, pp. 1681-1690
Risultati:
1-19
|